您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > (Rac)-CFT7455
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
(Rac)-CFT7455
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
(Rac)-CFT7455图片
规格:98%
分子量:469.53
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
(Rac)-CFT7455 是一种 Ikaros/Aiolos 降解剂,通过泛素蛋白酶体途径起作用,对 NCIH929.1 细胞的 GI50 为 0.05 nM。(Rac)-CFT7455 是具有抗癌活性的 CFT7455 的外消旋异构体。
货号:ajcx39656
CAS:2504233-68-3
分子式:C28H27N3O4
分子量:469.53
溶解度:DMSO : 62.5 mg/mL (133.11 mM; ultrasonic and warming and heat to 60°C)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

(Rac)-CFT7455 is a zinc finger transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) degrader, acting via the ubiquitin proteasome pathway, with a GI50 of 0.05 nM for NCIH929.1 cells. (Rac)-CFT7455 is the racemic isomer of CFT7455 which is a IKZF1/IKZF3 degrader with anticancer activity[1][2].

[1]. David Proia et al. Advantageous therapies for disorders mediated by ikaros or aiolos. WO2022032132A1 (compound 5)
[2]. James A. Henderson, et al. Abstract LB007: CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models. Cancer Res (2021) 81 (13_Supplement): LB007.